Medication info

CarbPin Tablet 60/5 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate Granules›150mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Boryung Biopharma Co., Ltd.
Appearance
Dark yellow apple-shaped film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201603154 · Approved 2016.05.31

Summary

Main use
Treatment of essential hypertension not controlled by fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted with fimasartan before starting this medicine; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 30/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy or 30/5 mg. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or 60/5 mg. Patients taking fimasartan and amlodipine concomitantly may switch to this medicine (a combination product with the same strengths of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy have not been established in pediatric and adolescent patients aged 18 years or younger.

Ingredients

Manufacturer
Boryung Biopharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by fimasartan monotherapy

  • Essential Hypertension
View approved original text

Pimasartan potassium is used additionally to effectively control blood pressure when monotherapy is insufficiently controlling blood pressure in patients with essential hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted with fimasartan before starting this medicine; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 30/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy or 30/5 mg. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or 60/5 mg. Patients taking fimasartan and amlodipine concomitantly may switch to this medicine (a combination product with the same strengths of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy have not been established in pediatric and adolescent patients aged 18 years or younger.

Precautions

This medication may cause serious harm to the fetus and newborn if taken during the 2nd and 3rd trimesters of pregnancy; therefore, if pregnancy is confirmed, treatment should be discontinued immediately. This medication should not be used in patients with allergies to the active ingredient or related ingredients, those who are pregnant or nursing, patients undergoing kidney dialysis, patients with moderate or severe liver dysfunction, patients with biliary obstruction, patients with certain kidney diseases or diabetic nephropathy, lactose-intolerant patients, patients with severe aortic stenosis, or patients in shock. Patients with reduced blood volume or salt levels, impaired kidney function, renovascular hypertension, aortic or mitral stenosis, primary aldosteronism, severe hypotension, elderly patients, and patients allergic to specific pigments should use this medication with special caution. Taking this medication may cause side effects such as dizziness, headache, edema, urinary disturbances, and insomnia. Rarely, severe kidney issues or blood pressure drops may occur, so if any unusual symptoms arise, consult a healthcare professional immediately. This medication lowers blood pressure, so care should be taken to avoid excessively low blood pressure or electrolyte imbalances, especially when taking diuretics or in cases of dehydration. Due to the risk of elevated serum potassium levels, patients with heart or kidney conditions should have regular blood tests. Drug interactions may occur when taken with other antihypertensive medications, specific diuretics, lithium, non-steroidal anti-inflammatory drugs, or certain antifungal agents; therefore, all medications being taken should be disclosed to healthcare providers. Pregnant or nursing women are advised not to use this medication, and if necessary, consult a doctor to select a safe alternative. The safety for use in children and adolescents under 18 years of age has not been established, so it is recommended not to use. Elderly patients may be more sensitive to this medication, so caution is needed; it should not be administered to patients with severe liver dysfunction. In case of overdose, severe hypotension or heart abnormalities may occur, and immediate medical attention should be sought. This medication must be stored out of reach of children, and transferring it to another container may compromise its quality, so caution is advised. During treatment, drowsiness or dizziness may occur, so caution should be exercised when driving vehicles or operating dangerous machinery.

Side effects

Dizziness, headache, postural dizziness, facial swelling, peripheral edema, urinary disturbance, insomnia, syncope, sedation, migraine, dyspepsia, vomiting, nausea, upper abdominal pain, weakness, foreign body sensation, elevated liver enzyme levels, decreased platelet count, increased serum creatine phosphokinase activity, cough, muscle contraction, musculoskeletal stiffness, pruritus, localized urticaria, facial flushing, flushing, erectile dysfunction, epilepsy, amyotrophic lateral sclerosis, neuropathy, neuronitis, facial paralysis, normal pressure hydrocephalus, spinal stenosis, acute pancreatitis, bowel obstruction, hemorrhagic duodenal ulcer, appendicitis, hemorrhoids, abdominal pain, intracranial hemorrhage, transient ischemic attack, atherosclerosis, deterioration of cerebral infarction, cerebral hemorrhage, liver cancer, colorectal carcinoma, neoplasm of unspecified nature, cervical cancer, prostate cancer, acute kidney failure, chronic kidney failure, kidney stones, pyelonephritis, urinary incontinence, rhinitis, fibrosing alveolitis, pharyngitis, pneumonia, lung disease, death, worsening of low back pain, osteoarthritis, arthropathy, hypoglycemia, hyperkalemia, pulmonary embolism, purpura, bradycardia, atrial fibrillation, coronary artery disease, aortic stenosis, heart failure, hypertension, acute hepatitis, benign pituitary neoplasm, otitis media, uterine prolapse, recurrent cancer, cerebral infarction, fracture, chest pain, weakness, fatigue, pain, weight gain, weight loss, increased tension, sensory loss, paresthesia, peripheral neuropathy, taste disturbance, tremor, extrapyramidal disorder, gynecomastia, change in bowel habits, dry mouth, gingival hyperplasia, pancreatitis, hyperglycemia, arthralgia, low back pain, muscle cramp, myalgia, leukopenia, thrombocytopenia, cough, dyspnea, rhinitis, alopecia, hyperhidrosis, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, subjective tinnitus, visual disturbance, increased urinary frequency, urinary disturbance, nocturia, hepatitis, jaundice, elevated liver enzyme levels, pruritus, rash, angioedema, polymorphic eruption, myocardial infarction, arrhythmia, bradycardia, ventricular tachycardia, atrial flutter, chest pain, hypotension, sinoatrial block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, constipation, skin erythema, petechial papular rash, heaviness, warmth, reduced oral glucose tolerance, frailty

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light; therefore, it should be stored in a container that blocks light. Additionally, it should be stored at room temperature between 1 to 30 degrees Celsius. This helps maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

Dark yellow apple-shaped film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.